Montag A & Associates Inc Eli Lilly & CO Transaction History

Montag A & Associates Inc

  • $2.09 Billion
  • Q3 2024

A detailed history of Montag A & Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Montag A & Associates Inc holds 28,614 shares of LLY stock, worth $22.8 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
28,614
Previous 27,351 4.62%
Holding current value
$22.8 Million
Previous $24.8 Million 2.37%
% of portfolio
1.21%
Previous 1.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$772.14 - $960.02 $975,212 - $1.21 Million
1,263 Added 4.62%
28,614 $25.4 Million
Q2 2024

Jul 31, 2024
SELL
$724.87 - $909.04 $300,821 - $377,251
-415 Reduced 1.49%
27,351 $24.8 Million
Q1 2024

May 07, 2024
SELL
$592.2 - $792.28 $737,289 - $986,388
-1,245 Reduced 4.29%
27,766 $21.6 Million
Q4 2023

Feb 07, 2024
SELL
$525.19 - $619.13 $444,835 - $524,403
-847 Reduced 2.84%
29,011 $16.9 Million
Q3 2023

Nov 09, 2023
SELL
$434.7 - $599.3 $254,734 - $351,189
-586 Reduced 1.92%
29,858 $16 Million
Q2 2023

Aug 09, 2023
SELL
$350.74 - $468.98 $1.36 Million - $1.82 Million
-3,887 Reduced 11.32%
30,444 $14.3 Million
Q1 2023

May 11, 2023
SELL
$310.63 - $364.82 $1.29 Million - $1.51 Million
-4,138 Reduced 10.76%
34,331 $11.8 Million
Q4 2022

Feb 02, 2023
SELL
$321.55 - $374.67 $481,360 - $560,880
-1,497 Reduced 3.75%
38,469 $14.1 Million
Q3 2022

Nov 09, 2022
SELL
$296.48 - $337.87 $252,008 - $287,189
-850 Reduced 2.08%
39,966 $12.9 Million
Q2 2022

Aug 10, 2022
SELL
$278.73 - $327.27 $129,051 - $151,526
-463 Reduced 1.12%
40,816 $13.2 Million
Q1 2022

May 02, 2022
SELL
$234.69 - $291.66 $47,407 - $58,915
-202 Reduced 0.49%
41,279 $11.8 Million
Q4 2021

Feb 09, 2022
BUY
$224.85 - $279.04 $3.22 Million - $4 Million
14,320 Added 52.72%
41,481 $11.5 Million
Q3 2021

Nov 08, 2021
SELL
$221.6 - $272.71 $89,526 - $110,174
-404 Reduced 1.47%
27,161 $6.28 Million
Q2 2021

Aug 03, 2021
SELL
$180.55 - $233.54 $257,283 - $332,794
-1,425 Reduced 4.92%
27,565 $6.33 Million
Q1 2021

May 14, 2021
BUY
$164.32 - $212.72 $5,422 - $7,019
33 Added 0.11%
28,990 $5.42 Million
Q4 2020

Feb 12, 2021
SELL
$130.46 - $172.63 $1,435 - $1,898
-11 Reduced 0.04%
28,957 $4.89 Million
Q3 2020

Nov 12, 2020
SELL
$146.22 - $169.13 $29,244 - $33,826
-200 Reduced 0.69%
28,968 $4.29 Million
Q2 2020

Aug 04, 2020
SELL
$136.42 - $164.18 $13,641 - $16,418
-100 Reduced 0.34%
29,168 $4.79 Million
Q1 2020

May 06, 2020
SELL
$119.05 - $147.35 $631,322 - $781,397
-5,303 Reduced 15.34%
29,268 $4.06 Million
Q4 2019

Feb 05, 2020
SELL
$106.92 - $132.43 $160,380 - $198,645
-1,500 Reduced 4.16%
34,571 $4.54 Million
Q3 2019

Nov 04, 2019
SELL
$106.79 - $116.16 $158,262 - $172,149
-1,482 Reduced 3.95%
36,071 $4.03 Million
Q2 2019

Aug 06, 2019
SELL
$110.79 - $129.32 $2.7 Million - $3.15 Million
-24,355 Reduced 39.34%
37,553 $4.16 Million
Q1 2019

May 01, 2019
SELL
$111.31 - $131.02 $3.34 Million - $3.93 Million
-30,010 Reduced 32.65%
61,908 $8.03 Million
Q4 2018

Feb 06, 2019
SELL
$105.9 - $118.64 $188,290 - $210,941
-1,778 Reduced 1.9%
91,918 $10.6 Million
Q3 2018

Nov 07, 2018
BUY
$85.86 - $107.31 $4.74 Million - $5.92 Million
55,180 Added 143.27%
93,696 $10.1 Million
Q2 2018

Aug 01, 2018
SELL
$75.7 - $86.88 $20,817 - $23,892
-275 Reduced 0.71%
38,516 $3.29 Million
Q1 2018

May 07, 2018
SELL
$74.21 - $87.6 $128,086 - $151,197
-1,726 Reduced 4.26%
38,791 $3 Million
Q4 2017

Feb 09, 2018
SELL
$81.94 - $87.89 $135,119 - $144,930
-1,649 Reduced 3.91%
40,517 $3.42 Million
Q3 2017

Nov 06, 2017
BUY
$77.07 - $85.54 $3.25 Million - $3.61 Million
42,166
42,166 $3.61 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email